← Evidence map

ArticleeLife2019

A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma.

Wenna Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

46 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31169496